Nuvation Bio Inc (NUVB NYSE) stock market data APIs
$4.4535
0.28(6.3%)
as of October 16, 2026
Try our APIs with
free plan!
Nuvation Bio Inc Financial Data Overview
Price chart is built with
Anychart
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company's lead product candidate is IBTROZI (taletrectinib), a ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. It is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 3 clinical trials for the maintenance treatment of high-risk or high-grade IDH1-mutant astrocytoma with safusidenib against placebo. The company was founded in 2018 and is headquartered in New York, New York.
Prev. Close
4.4535
Open
4.7288
High
4.7406
Low
4.4285
52 wk Range
3.45-9.75
Market Cap
1 562 M
Shares Outstanding
350 M
Revenue
170 M
EPS
-0.15
Beta
1.617
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Nuvation Bio Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Nuvation Bio Inc data using free add-ons & libraries
Get Nuvation Bio Inc Fundamental Data
Nuvation Bio Inc Fundamental data includes:
- Net Revenue: 170 M
- EBITDA: -135 480 992
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-06
- EPS/Forecast: -0.15
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Nuvation Bio Inc News
New
Nextdoor Stock And 2 Healthy Penny Stocks To Own
Higher interest rates are hitting big tech and highly priced growth stories hard, as recent AI related sell offs have shown. That pullback is pushing more investors to look at smaller, lower priced sh...
Top 3 Penny Stocks To Watch In October 2026
The Iran war has pushed oil shipping costs to record highs, and that pressure on energy and transport is forcing money to look harder at smaller, nimbler businesses. Investors are hunting for low pric...
Ventia Services Group And 2 Top Penny Stocks
Rising Treasury yields and the prospect of higher US interest rates are making expensive growth stories harder to justify, which is pushing more investors toward smaller companies with stronger financ...
Top Penny Stocks To Own In October 2026
Spiking Treasury yields have pushed many investors back toward safer assets, which has punished weaker balance sheets and rewarded stronger ones. That creates an opening for you. Solid, low priced com...
Get Nuvation Bio Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.